The methyltransferase METTL3 promotes tumorigenesis via mediating HHLA2 mRNA m6A modification in human renal cell carcinoma

Table 1 Correlation between the METTL3 expression and patients’ clinical parameters

Clinical parameters	Cases	METTL3 expression level		χ²	P
Clinical parameters	Cases	H-score < 170	H-score ≥ 170	χ²	P
Gender				0.382	0.536
Male	54	29	25
Female	30	14	16
Age (years)				1.810	0.179
≤ 60	47	21	26
> 60	37	22	15
Pathological stage				0.147	0.701
I + II	57	30	27
III + IV	27	13	14
Tumor size (diameter: cm)				3.827	0.051
< 5	40	16	24
≥ 5	44	27	17
Tumor position				0.186	0.666
Left	43	23	20
Right	41	20	21
T stage				0.026	0.871
I	54	28	26
II + III	30	15	15
Distance metastasis				2.149	0.143
M₀	82	43	39
M₁	2	0	2
TNM stage				0.825	0.364
I + II	78	41	37
III + IV	6	2	4

ISSN: 1479-5876